HER2Δ16激活ENPP1以促进乳腺癌中的免疫冷微环境
Sherif Samer Attalla1,2, Jonathan Boucher3, Hailey Proud1,2
1Department of Biochemistry, Faculty of Medicine and Health Sciences, McGill University, Montreal, Canada.
Cancer immunology research
|June 13, 2023
概括
HER2Δ16,一种乳腺癌变体,创造了一个免疫冷瘤微环境. 向ENPP1可能会扭转这种情况,为侵袭性HER2+乳腺癌提供新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 瘤免疫微环境 (TIME) 极大地影响了癌症治疗反应.
- 调节时间调节的机制尚未完全理解.
- HER2Δ16是一种致癌的HER2结合变体,驱动乳腺癌的瘤发生和转移.
研究的目的:
- 研究HER2变种在调节瘤微环境中的作用.
- 阐明HER2Δ16介导的致癌性机制.
- 为了确定在激进的HER2+乳腺癌中潜在的治疗点.
主要方法:
- 在乳腺上皮表皮表达HER2或HER2Δ16的转基因小鼠模型.
- 利用表皮细胞表面蛋白质分析来确定关键的调节者.
- 创建了HER2Δ16的模拟模型,并进行了基因淘汰实验.
主要成果:
- HER2Δ16瘤表现出一种免疫感冒表型,免疫细胞透率低.
- 乙核酸铁酸盐酶/化酶1 (ENPP1) 被确定为免疫冷微环境的调节者.
- 在HER2Δ16瘤中,ENPP1的淘汰减少了瘤的生长,增加了T细胞的透.
结论:
- 在乳腺癌中,HER2Δ16的表达与不良的临床结果和免疫抑制的TIME有关.
- 通过免疫调节,依赖HER2Δ16的ENPP1激活有助于激进的HER2+乳腺癌.
- ENPP1代表了对激进的HER2+乳腺癌的有前途的治疗标.
更多相关视频
07:03Isolation and Functional Assessment of Human Breast Cancer Stem Cells from Cell and Tissue Samples
Published on: October 2, 2020
4.6K
07:20Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation
Published on: January 14, 2011
14.8K
相关概念视频
The Tumor Microenvironment
6.7K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
Mitogens and the Cell Cycle
6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
2.3K
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.3K
Receptor Downregulation in MVBs
2.1K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.1K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
